No Data
No Data
No Data
Cotuo Biotech (300858.SZ) grants 2.6 million restricted shares at a grant price of 13 yuan/share
Ketuo Biotech (300858.SZ) announced that restricted shares stipulated in the company's 2024 restricted stock incentive plan...
Cotuo Biotech (300858.SZ) reported 2023 annual results, net profit of 93.4799 million yuan, a year-on-year decrease of 14.93%
Cotuo Biotech (300858.SZ) released its 2023 annual report, with revenue of 299 million yuan, a year-on-year decrease...
Cotuo Biotech (300858.SZ) plans to grant no more than 3 million restricted shares at a grant price of 13 yuan/share
Cotuo Biotech (300858.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft), and the company plans to promote...
Ketuo Biotech (300858.SZ): Some fund-raising projects to be postponed
Gelonghui, December 29, 丨 Ketuo Biotech (300858.SZ) announced that the company held the 4th meeting of the 3rd board of directors and the 4th meeting of the 3rd board of supervisors on December 29, 2023 to review and pass the “Proposal on the Extension of Fund-raising Projects”, agreeing that the company will adjust the time when the fund-raising project implementation entity, implementation method, investment use and investment scale of the fund-raising project will not change. The bill does not need to be submitted to the company's shareholders' meeting for consideration. Although the feasibility of this fund-raising project was fully demonstrated in the early stages, it was actually implemented by many parties
Ketuo Biology (300858.SZ): Currently, there is no collaboration with Bacteria Xiaobao
Glonghui December 1: Some investors asked Ketuo Biotech (300858.SZ) on the investor interactive platform, “Is Yu Xiaobao a customer of your company?” The company replied that at present, the company has not cooperated with Bacteria Xiaobao.
Liu Xiaojun, shareholder of Ketuo Biotech (300858.SZ), terminated the holdings reduction plan early and did not reduce his holdings
Ketuo Biotech (300858.SZ) announced that as of November 21, 2023, the current holdings reduction plan is already...
No Data